Ocular Therapeutix Drug Patent Portfolio
Ocular Therapeutix owns 1 orange book drug protected by 4 US patents Given below is the list of Ocular Therapeutix's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11458041 | Punctal plug and bioadhesives | 16 Nov, 2037 | Active |
| US8409606 | Drug delivery through hydrogel plugs | 14 May, 2030 | Active |
| US8563027 | Drug delivery through hydrogel plugs | 12 Feb, 2030 | Active |
| US9254267 | Composite hydrogel drug delivery systems | 11 Sep, 2024 | Expired |
Latest Legal Activities on Ocular Therapeutix's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ocular Therapeutix.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Oct, 2022 | US11458041 |
|
Recordation of Patent Grant Mailed
Critical
| 04 Oct, 2022 | US11458041 |
|
Email Notification
Critical
| 15 Sep, 2022 | US11458041 |
|
Issue Notification Mailed
Critical
| 14 Sep, 2022 | US11458041 |
| Dispatch to FDC | 30 Aug, 2022 | US11458041 |
|
Application Is Considered Ready for Issue
Critical
| 30 Aug, 2022 | US11458041 |
|
Issue Fee Payment Verified
Critical
| 26 Aug, 2022 | US11458041 |
|
Issue Fee Payment Received
Critical
| 26 Aug, 2022 | US11458041 |
|
Electronic Review
Critical
| 02 Aug, 2022 | US11458041 |
|
Email Notification
Critical
| 02 Aug, 2022 | US11458041 |
|
Mail Notice of Allowance
Critical
| 02 Aug, 2022 | US11458041 |
|
Notice of Allowance Data Verification Completed
Critical
| 29 Jul, 2022 | US11458041 |
| Date Forwarded to Examiner | 21 Jul, 2022 | US11458041 |
|
Information Disclosure Statement considered
Critical
| 13 Jul, 2022 | US11458041 |
| Interview Summary - Applicant Initiated - Telephonic | 13 Jul, 2022 | US11458041 |
Ocular Therapeutix's Family Patents
Ocular Therapeutix Drug List
Given below is the complete list of Ocular Therapeutix's drugs and the patents protecting them.
1. Dextenza
Dextenza is protected by 4 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11458041 | Punctal plug and bioadhesives |
16 Nov, 2037
(12 years from now)
| Active |
| US8409606 | Drug delivery through hydrogel plugs |
14 May, 2030
(5 years from now)
| Active |
| US8563027 | Drug delivery through hydrogel plugs |
12 Feb, 2030
(5 years from now)
| Active |
| US9254267 | Composite hydrogel drug delivery systems |
11 Sep, 2024
(4 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dextenza's drug page